Question for those more knowledgeable than me abou
Post# of 150980

Is the start of a trial a PR moment?
The reason I ask is as follows:
We all know how the new management has kept everything hush hush. If I’m not mistaken the current trial is open so the data can be reviewed throughout the trial?
Is it even possible that the trial has started, patients have been receiving Leronlimab since January? If possible how long would it take before there would be potential noticeable results from Leronlimab?
Could they be waiting and going to present some initial data? We are approaching the end of the first quarter and I have been thinking outside the box here wondering if something like this is even plausible??
Does anyone understand where I’m going with this?
Thoughts??

